首页 > 最新文献

Digestive Surgery最新文献

英文 中文
Vagal Sparing Gastrectomy: A Systematic Review and Meta-Analysis. 迷走神经保留胃切除术:系统回顾和荟萃分析。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-02-27 DOI: 10.1159/000536472
Ashraf M Tokhi, Sam V George, Carlos S Cabalag, David S Liu, Cuong P Duong

Introduction: Radical gastrectomy is associated with significant functional complications. In appropriate patients may be amenable to less invasive resection aimed at preserving the vagal trunks. The aim of this systematic review and meta-analysis was to assess the functional consequences and oncological safety of vagal sparing gastrectomy (VSG) compared to conventional non-vagal sparing gastrectomy (CG).

Methods: A systematic review of four databases in accordance with PRISMA guidelines was undertaken for studies published between January 1, 1990, and December 15, 2021, comparing patients who underwent VSG to CG. We meta-analysed the following outcomes: operative time, blood loss, nodal yield, days to flatus, body weight changes, as well as the incidence of post-operative cholelithiasis, diarrhoea, delayed gastric emptying, and dumping syndrome.

Results: Thirty studies were included in the meta-analysis with a selection of studies qualitatively analysed. VSG was associated with a lower rate of cholelithiasis (OR: 0.25, 95% CI: 0.15-0.41, p < 0.010) and early dumping syndrome (OR: 0.42, 95% CI: 0.21-0.86; p = 0.02), less blood loss (mean difference [MD]: -51 mL, 95% CI: -89.11 to -12.81 mL, p = 0.009), less long-term weight loss (MD: 2.03%, 95% CI: 0.31-3.76%, p = 0.02) and a faster time to flatus (MD: -0.42 days, 95% CI: -0.48 to 0.36, p < 0.001). There was no significant difference in nodal harvest, overall survival, and all other endpoints.

Conclusion: VSG significantly reduces the incidence of post-operative cholelithiasis and dumping syndrome, decreases weight loss, and facilitates an earlier return of gut motility. Although technically more challenging, VSG should be considered for prophylactic surgery.

根治性胃切除术与严重的功能性并发症有关。在适当的情况下,患者可以采用旨在保留迷走神经干的微创切除术。本系统综述和荟萃分析旨在评估迷走神经保留胃切除术(VSG)与传统非迷走神经保留胃切除术(CG)相比的功能性后果和肿瘤安全性。我们对四个数据库中发表于 1990 年 11 月 1 日至 2021 年 12 月 15 日之间的研究进行了系统性回顾,比较了接受 VSG 和 CG 的患者。我们对以下结果进行了荟萃分析:手术时间、失血量、结节率、排气天数、体重变化以及术后胆石症、腹泻、胃排空延迟和倾倒综合征的发生率。荟萃分析纳入了 30 项研究,并对部分研究进行了定性分析。VSG 与较低的胆石症发生率相关(OR 0.25,95% CI 0.15-0.41, p
{"title":"Vagal Sparing Gastrectomy: A Systematic Review and Meta-Analysis.","authors":"Ashraf M Tokhi, Sam V George, Carlos S Cabalag, David S Liu, Cuong P Duong","doi":"10.1159/000536472","DOIUrl":"10.1159/000536472","url":null,"abstract":"<p><strong>Introduction: </strong>Radical gastrectomy is associated with significant functional complications. In appropriate patients may be amenable to less invasive resection aimed at preserving the vagal trunks. The aim of this systematic review and meta-analysis was to assess the functional consequences and oncological safety of vagal sparing gastrectomy (VSG) compared to conventional non-vagal sparing gastrectomy (CG).</p><p><strong>Methods: </strong>A systematic review of four databases in accordance with PRISMA guidelines was undertaken for studies published between January 1, 1990, and December 15, 2021, comparing patients who underwent VSG to CG. We meta-analysed the following outcomes: operative time, blood loss, nodal yield, days to flatus, body weight changes, as well as the incidence of post-operative cholelithiasis, diarrhoea, delayed gastric emptying, and dumping syndrome.</p><p><strong>Results: </strong>Thirty studies were included in the meta-analysis with a selection of studies qualitatively analysed. VSG was associated with a lower rate of cholelithiasis (OR: 0.25, 95% CI: 0.15-0.41, p &lt; 0.010) and early dumping syndrome (OR: 0.42, 95% CI: 0.21-0.86; p = 0.02), less blood loss (mean difference [MD]: -51 mL, 95% CI: -89.11 to -12.81 mL, p = 0.009), less long-term weight loss (MD: 2.03%, 95% CI: 0.31-3.76%, p = 0.02) and a faster time to flatus (MD: -0.42 days, 95% CI: -0.48 to 0.36, p &lt; 0.001). There was no significant difference in nodal harvest, overall survival, and all other endpoints.</p><p><strong>Conclusion: </strong>VSG significantly reduces the incidence of post-operative cholelithiasis and dumping syndrome, decreases weight loss, and facilitates an earlier return of gut motility. Although technically more challenging, VSG should be considered for prophylactic surgery.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"147-160"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139982554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
N3 Disease in Esophageal Cancer: Results from a Nationwide Registry. 食管癌中的 N3 疾病:来自全国登记处的结果。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-03 DOI: 10.1159/000540468
Charlène J van der Zijden, Pim B Olthof, Pieter C van der Sluis, Bas P L Wijnhoven, Maria Erodotou, Henk H Hartgrink, Boudewijn van Etten, Stijn van Esser, Sjoerd M Lagarde, Jan Willem T Dekker

Background: Patients with extensive lymph node metastases have a poor prognosis. Clinical staging of lymph node metastases poses significant challenges given the limited sensitivity and specificity of imaging techniques. The aim of this study was to investigate the overall survival (OS) of patients with N3 disease in a real-world Dutch population and the added value of surgery in these patients.

Methods: Patients with cN3M0 esophageal or gastroesophageal cancer were identified from the Netherlands Cancer Registry (2012-2019). Treatment consisted of neoadjuvant chemo(radio)therapy followed by resection or chemo(radio)therapy, radiotherapy, or esophagectomy alone. OS was calculated using the Kaplan-Meier method.

Results: Some 21,566 patients were diagnosed with esophageal cancer of whom 359 (1.7%) had cN3M0 disease. Median OS of these patients was 12.5 months (95% CI: 10.7-14.3). Median OS following chemoradiotherapy alone and neoadjuvant therapy plus surgery was 13.3 months (95% CI: 10.7-15.9) and 23.7 months (95% CI: 18.3-29.2), respectively. Of all patients who underwent esophagectomy, 391 (2.8%) had (y)pN3 disease, and median OS was 16.1 months (95% CI: 14.8-17.4). Twenty-one patients (5.4%) were correctly classified as cN3, and 3-year OS was 21%.

Conclusion(s): Clinical staging appears to be difficult, apparently in patients with N3 esophageal cancer. Surgery seems to be of benefit to these patients. More research is required to address the ongoing challenges in clinical staging and the best neoadjuvant therapy.

背景:有广泛淋巴结转移的患者预后较差。由于成像技术的敏感性和特异性有限,淋巴结转移的临床分期面临巨大挑战。本研究旨在调查荷兰真实人群中 N3 疾病患者的总生存率(OS)以及手术对这些患者的附加价值:方法:从荷兰癌症登记处(2012-2019年)中确定了cN3M0食管癌或胃食管癌患者。治疗方法包括新辅助化疗(放疗)、切除术或化疗(放疗)、放疗或单纯食管切除术。采用Kaplan-Meier法计算OS:结果:约 21 566 名食管癌患者被确诊为食管癌,其中 359 人(1.7%)患有 cN3M0 疾病。这些患者的中位生存期为 12.5 个月(95% CI 10.7-14.3)。单纯化放疗和新辅助治疗加手术的中位生存期分别为13.3个月(95% CI 10.7-15.9)和23.7个月(95% CI 18.3-29.2)。在所有接受食管切除术的患者中,有 391 人(2.8%)患有 (y)pN3 疾病,中位 OS 为 16.1 个月(95% CI 14.8-17.4)。21名患者(5.4%)被正确分类为cN3,3年生存率为21%:结论:临床分期似乎很困难,N3食管癌患者尤其如此。手术似乎对这些患者有益。要解决临床分期和最佳新辅助治疗方面的难题,还需要更多的研究。
{"title":"N3 Disease in Esophageal Cancer: Results from a Nationwide Registry.","authors":"Charlène J van der Zijden, Pim B Olthof, Pieter C van der Sluis, Bas P L Wijnhoven, Maria Erodotou, Henk H Hartgrink, Boudewijn van Etten, Stijn van Esser, Sjoerd M Lagarde, Jan Willem T Dekker","doi":"10.1159/000540468","DOIUrl":"10.1159/000540468","url":null,"abstract":"<p><strong>Background: </strong>Patients with extensive lymph node metastases have a poor prognosis. Clinical staging of lymph node metastases poses significant challenges given the limited sensitivity and specificity of imaging techniques. The aim of this study was to investigate the overall survival (OS) of patients with N3 disease in a real-world Dutch population and the added value of surgery in these patients.</p><p><strong>Methods: </strong>Patients with cN3M0 esophageal or gastroesophageal cancer were identified from the Netherlands Cancer Registry (2012-2019). Treatment consisted of neoadjuvant chemo(radio)therapy followed by resection or chemo(radio)therapy, radiotherapy, or esophagectomy alone. OS was calculated using the Kaplan-Meier method.</p><p><strong>Results: </strong>Some 21,566 patients were diagnosed with esophageal cancer of whom 359 (1.7%) had cN3M0 disease. Median OS of these patients was 12.5 months (95% CI: 10.7-14.3). Median OS following chemoradiotherapy alone and neoadjuvant therapy plus surgery was 13.3 months (95% CI: 10.7-15.9) and 23.7 months (95% CI: 18.3-29.2), respectively. Of all patients who underwent esophagectomy, 391 (2.8%) had (y)pN3 disease, and median OS was 16.1 months (95% CI: 14.8-17.4). Twenty-one patients (5.4%) were correctly classified as cN3, and 3-year OS was 21%.</p><p><strong>Conclusion(s): </strong>Clinical staging appears to be difficult, apparently in patients with N3 esophageal cancer. Surgery seems to be of benefit to these patients. More research is required to address the ongoing challenges in clinical staging and the best neoadjuvant therapy.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"133-140"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11382634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Albumin-Lymphocyte-Globulin-C-Reactive Protein Index as a Novel Prognostic Biomarker for Hepatocellular Carcinoma after Hepatectomy. 白蛋白-淋巴细胞-球蛋白-C-反应蛋白指数作为肝切除术后肝细胞癌的新型预后生物标志物
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-07-22 DOI: 10.1159/000540067
Masashi Utsumi, Masaru Inagaki, Koji Kitada, Naoyuki Tokunaga, Kosuke Yunoki, Yuya Sakurai, Hiroki Okabayashi, Ryosuke Hamano, Hideaki Miyaso, Yosuke Tsunemitsu, Shinya Otsuka

Introduction: This study evaluated the performance of the albumin-lymphocyte-globulin-C-reactive protein (CRP) (ALGC) index as a novel prognostic biomarker for hepatocellular carcinoma (HCC) after hepatectomy.

Methods: Patients (n = 178) who underwent hepatectomy for HCC (July 2010-December 2021) were analyzed. The ALGC index was calculated as ([albumin × lymphocyte]/[CRP × globulin × 104]). Patients were divided into a low ALGC group (<1.82; n = 81) and a high ALGC group (≥1.82; n = 97). The association of the ALGC index with survival was assessed by univariate and multivariate analyses.

Results: The median overall survival (OS) was 100 (range: 1-149) months with 1-, 3-, and 5-year OS rates of 91.6%, 81.2%, and 64.2%, respectively. In univariate analysis, ALGC index (<1.82), alpha-fetoprotein (≥25 ng/mL), tumor size (≥3.5 cm), microvascular invasion, and multiple tumors were associated with shorter OS. ALGC index (<1.82) (hazard ratio [95% confidence interval]) (2.48 [1.407-4.513]; p = 0.001) and multiple tumors (1.92 [1.070-3.356]; p = 0.029) were independent predictors of OS in multivariate analysis.

Conclusion: ALGC index is a novel prognostic biomarker for HCC after hepatectomy. It may assist in treatment stratification and better management of patients with HCC.

简介本研究评估了白蛋白-淋巴细胞-球蛋白-C反应蛋白(CRP)(ALGC)指数作为肝细胞癌(HCC)肝切除术后新型预后生物标志物的性能:方法: 对2010年7月至2021年12月接受肝切除术的HCC患者(178人)进行分析。ALGC指数的计算公式为[(白蛋白×淋巴细胞)/(CRP×球蛋白×104)]。患者被分为低ALGC组(<1.82; n=81)和高ALGC组(≥1.82; n=97)。通过单变量和多变量分析评估了ALGC指数与生存期的关系:中位总生存期(OS)为100个月(范围:1-149),1年、3年和5年OS率分别为91.6%、81.2%和64.2%。在单变量分析中,ALGC指数(<1.82)、甲胎蛋白(≥25纳克/毫升)、肿瘤大小(≥3.5厘米)、微血管侵犯和多发肿瘤与较短的OS相关。在多变量分析中,ALGC指数(<1.82)(危险比[95%置信区间])(2.48 [1.407-4.513]; P=0.001)和多发肿瘤(1.92 [1.070-3.356]; P=0.029)是OS的独立预测因素:结论:ALGC指数是肝切除术后HCC的新型预后生物标志物。结论:ALGC指数是肝切除术后HCC的一种新的预后生物标志物,有助于对HCC患者进行治疗分层和更好的管理。
{"title":"Albumin-Lymphocyte-Globulin-C-Reactive Protein Index as a Novel Prognostic Biomarker for Hepatocellular Carcinoma after Hepatectomy.","authors":"Masashi Utsumi, Masaru Inagaki, Koji Kitada, Naoyuki Tokunaga, Kosuke Yunoki, Yuya Sakurai, Hiroki Okabayashi, Ryosuke Hamano, Hideaki Miyaso, Yosuke Tsunemitsu, Shinya Otsuka","doi":"10.1159/000540067","DOIUrl":"10.1159/000540067","url":null,"abstract":"<p><strong>Introduction: </strong>This study evaluated the performance of the albumin-lymphocyte-globulin-C-reactive protein (CRP) (ALGC) index as a novel prognostic biomarker for hepatocellular carcinoma (HCC) after hepatectomy.</p><p><strong>Methods: </strong>Patients (n = 178) who underwent hepatectomy for HCC (July 2010-December 2021) were analyzed. The ALGC index was calculated as ([albumin × lymphocyte]/[CRP × globulin × 104]). Patients were divided into a low ALGC group (&lt;1.82; n = 81) and a high ALGC group (≥1.82; n = 97). The association of the ALGC index with survival was assessed by univariate and multivariate analyses.</p><p><strong>Results: </strong>The median overall survival (OS) was 100 (range: 1-149) months with 1-, 3-, and 5-year OS rates of 91.6%, 81.2%, and 64.2%, respectively. In univariate analysis, ALGC index (&lt;1.82), alpha-fetoprotein (≥25 ng/mL), tumor size (≥3.5 cm), microvascular invasion, and multiple tumors were associated with shorter OS. ALGC index (&lt;1.82) (hazard ratio [95% confidence interval]) (2.48 [1.407-4.513]; p = 0.001) and multiple tumors (1.92 [1.070-3.356]; p = 0.029) were independent predictors of OS in multivariate analysis.</p><p><strong>Conclusion: </strong>ALGC index is a novel prognostic biomarker for HCC after hepatectomy. It may assist in treatment stratification and better management of patients with HCC.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"161-170"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Resection in Synchronous Bilobar versus Unilobar Colorectal Liver Metastases: A Retrospective Analysis of Oncological Outcomes and Patient Survival. 同步双叶与单叶结直肠肝转移的肝切除术:肿瘤结果和患者生存期的回顾性分析。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-05-03 DOI: 10.1159/000538359
Christian Stoess, Benjamin Mirschinka, Johanna Ollesky, Marcella Steffani, Nick Seyfried, Benedikt Kaufmann, Helmut Friess, Norbert Hüser, Ulrich Nitsche, Daniel Hartmann

Introduction: Resection of colorectal liver metastasis has emerged as the standard treatment. Our study compares oncological outcomes of patients with resected synchronous bilobar versus unilobar colorectal liver metastasis.

Methods: This retrospective study presents long-term follow-up data of 105 consecutive patients with primary colorectal cancer and synchronous liver metastasis. All patients underwent primary tumor and metastasis resections between 2007 and 2019.

Results: Fifty-five patients with bilobar and 50 patients with unilobar colorectal liver metastases were included. No significant difference in overall, tumor-specific, or recurrence-free survival was observed between patients with bilobar and unilobar metastases. After case-control matching, the results were confirmed in patients with similar tumor burdens. In the multivariate analysis, chemotherapy following liver metastasis resection was a significant prognostic factor associated with improved overall survival (hazard ratio 0.518, 95% confidence interval: 0.302-0.888, p = 0.017).

Conclusion: Overall survival, as well as tumor-specific and recurrence-free survival, did not differ between patients with unilobar and bilobar liver metastasis. These findings contribute to the understanding that primary tumor and metastasis resection in eligible patients improve long-term outcomes.

简介:大肠肝转移瘤切除术已成为标准治疗方法:结直肠肝转移瘤切除术已成为标准治疗方法。我们的研究比较了切除同步双叶与单叶结直肠肝转移瘤患者的肿瘤治疗效果:这项回顾性研究提供了连续 105 例原发性结直肠癌和同步肝转移患者的长期随访数据。所有患者均在 2007 年至 2019 年期间接受了原发肿瘤和转移灶切除术:结果:共纳入55例双叶结直肠癌肝转移患者和50例单叶结直肠癌肝转移患者。双叶和单叶转移患者的总生存期、肿瘤特异性生存期和无复发生存期均无明显差异。经过病例对照匹配后,结果在肿瘤负荷相似的患者中得到了证实。在多变量分析中,肝转移灶切除术后化疗是与总生存率改善相关的重要预后因素(危险比 0.518,95% 置信区间:0.302-0.888,P = 0.017):结论:单叶和双叶肝转移患者的总生存期、肿瘤特异性生存期和无复发生存期没有差异。这些研究结果有助于人们理解,对符合条件的患者进行原发肿瘤和转移瘤切除可改善长期预后。
{"title":"Liver Resection in Synchronous Bilobar versus Unilobar Colorectal Liver Metastases: A Retrospective Analysis of Oncological Outcomes and Patient Survival.","authors":"Christian Stoess, Benjamin Mirschinka, Johanna Ollesky, Marcella Steffani, Nick Seyfried, Benedikt Kaufmann, Helmut Friess, Norbert Hüser, Ulrich Nitsche, Daniel Hartmann","doi":"10.1159/000538359","DOIUrl":"10.1159/000538359","url":null,"abstract":"<p><strong>Introduction: </strong>Resection of colorectal liver metastasis has emerged as the standard treatment. Our study compares oncological outcomes of patients with resected synchronous bilobar versus unilobar colorectal liver metastasis.</p><p><strong>Methods: </strong>This retrospective study presents long-term follow-up data of 105 consecutive patients with primary colorectal cancer and synchronous liver metastasis. All patients underwent primary tumor and metastasis resections between 2007 and 2019.</p><p><strong>Results: </strong>Fifty-five patients with bilobar and 50 patients with unilobar colorectal liver metastases were included. No significant difference in overall, tumor-specific, or recurrence-free survival was observed between patients with bilobar and unilobar metastases. After case-control matching, the results were confirmed in patients with similar tumor burdens. In the multivariate analysis, chemotherapy following liver metastasis resection was a significant prognostic factor associated with improved overall survival (hazard ratio 0.518, 95% confidence interval: 0.302-0.888, p = 0.017).</p><p><strong>Conclusion: </strong>Overall survival, as well as tumor-specific and recurrence-free survival, did not differ between patients with unilobar and bilobar liver metastasis. These findings contribute to the understanding that primary tumor and metastasis resection in eligible patients improve long-term outcomes.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"103-110"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is reassessment of Computed Tomography Reports Worthwhile in Acute Diverticulitis? 急性憩室炎患者值得重新评估计算机断层扫描报告吗?
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-01-10 DOI: 10.1159/000536158
Leena-Mari Mäntymäki, Juha Grönroos, Anu Aronen, Jukka Karvonen, Mika Ukkonen

Introduction: Since the assessment of the disease severity in acute diverticulitis (AD) is of utmost importance to determine the optimal treatment and the need for follow-up investigations, we wanted to investigate whether the first CT report is compatible with daytime reassessment report and whether the value of initial report changes according to the experience of the radiologist.

Methods: Consecutive patients from tertiary referral centre with AD were included. CT images done in the emergency department were initially analysed by either resident radiologists or consultant radiologists and then later reanalysed by consultant abdominal radiologists. Discrepancies between reports were noted.

Results: Of total of 562 patients with AD, CT images were reanalysed in 439 cases. In 22 reports (5.0%) the final report was significantly different from the initial report and management changed in 20 cases. In reports of uncomplicated acute diverticulitis, reanalysis changed initial assessment in 4.0% of the cases and in complicated acute diverticulitis (CAD) in 9.1%. When consultant and resident radiologists were compared, there was no significant difference.

Conclusion: Although no statistical difference could be noted between residents and consultants, the final report was significantly different in overall 5% of the cases when reanalysed at normal working hours by an experienced consultant abdominal radiologist. Therefore, we conclude that reassessment of CT reports is worthwhile in AD.

引言 由于评估急性憩室炎(AD)的病情严重程度对于确定最佳治疗方案和是否需要进行后续检查至关重要,因此我们希望研究首次 CT 报告是否与日间复查报告一致,以及首次报告的价值是否会随着放射科医生经验的变化而改变。方法 纳入来自三级转诊中心的AD连续患者。急诊科的 CT 图像由放射科住院医生或放射科顾问医生进行初步分析,然后由腹部放射科顾问医生进行再次分析。报告之间的差异会被记录下来。结果 在 562 例 AD 患者中,有 439 例重新分析了 CT 图像。在 22 份报告(5.0%)中,最终报告与初始报告有显著差异,20 例患者的治疗方法发生了改变。在无并发症急性憩室炎(UAD)的报告中,4.0%的病例的重新分析改变了最初的评估,而在并发症急性憩室炎(CAD)的报告中,9.1%的病例的重新分析改变了最初的评估。顾问放射科医生和常驻放射科医生之间的比较没有显著差异。结论 虽然住院医生和顾问医生之间没有统计学差异,但由经验丰富的腹部放射顾问医生在正常工作时间重新进行分析时,5% 的病例的最终报告会有显著差异。因此,我们得出结论,在 AD 中重新评估 CT 报告是值得的。
{"title":"Is reassessment of Computed Tomography Reports Worthwhile in Acute Diverticulitis?","authors":"Leena-Mari Mäntymäki, Juha Grönroos, Anu Aronen, Jukka Karvonen, Mika Ukkonen","doi":"10.1159/000536158","DOIUrl":"10.1159/000536158","url":null,"abstract":"<p><strong>Introduction: </strong>Since the assessment of the disease severity in acute diverticulitis (AD) is of utmost importance to determine the optimal treatment and the need for follow-up investigations, we wanted to investigate whether the first CT report is compatible with daytime reassessment report and whether the value of initial report changes according to the experience of the radiologist.</p><p><strong>Methods: </strong>Consecutive patients from tertiary referral centre with AD were included. CT images done in the emergency department were initially analysed by either resident radiologists or consultant radiologists and then later reanalysed by consultant abdominal radiologists. Discrepancies between reports were noted.</p><p><strong>Results: </strong>Of total of 562 patients with AD, CT images were reanalysed in 439 cases. In 22 reports (5.0%) the final report was significantly different from the initial report and management changed in 20 cases. In reports of uncomplicated acute diverticulitis, reanalysis changed initial assessment in 4.0% of the cases and in complicated acute diverticulitis (CAD) in 9.1%. When consultant and resident radiologists were compared, there was no significant difference.</p><p><strong>Conclusion: </strong>Although no statistical difference could be noted between residents and consultants, the final report was significantly different in overall 5% of the cases when reanalysed at normal working hours by an experienced consultant abdominal radiologist. Therefore, we conclude that reassessment of CT reports is worthwhile in AD.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"37-41"},"PeriodicalIF":2.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139416652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colonic Diverticulosis at Colonoscopy in Africa: A Systematic Review and Meta-Analysis of Pooled Estimates. 非洲结肠镜检查中的结肠憩室病:系统综述和汇总估算的荟萃分析。
IF 1.8 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-02-20 DOI: 10.1159/000536587
Emeka Ray-Offor, Stella-Maris Egboh, Rex F O A Ijah, Sameh Hany Emile, Steven D Wexner

Introduction: There is need to ascertain any epidemiologic shift of diverticulosis among Africans with traditionally high fiber diet consumption patterns and rare diverticulosis prevalence.

Methods: We systematically searched PubMed, Scopus, Cochrane Library, African Journal Online (AJOL), and Google Scholar. Eligibility criteria included full-text observational and experimental human colonoscopy studies on asymptomatic and symptomatic African population from 1985 to 2022. Case reports, conference abstracts, dissertations, systematic reviews, and studies lacking colonoscopy findings were excluded. NIH quality assessment tool for observational cohort and cross-sectional studies was used to assess risk of bias. Meta-analysis was performed using the random-effect model. Heterogeneity was assessed using inconsistency (I2) statistics.

Results: Thirty studies were included. Pooled prevalence rate of colonic diverticulosis in the last decade (2012-2022) has increased to 9.7% (95% CI 6.5-13.4; I2 = 97.3%) from 3.5% (95% CI 1.4-6.4; I2 = 62.7%). The highest regional prevalence rate was in West African studies at 11.3% (95% CI 7.6-14.9; I2 = 96.2%). Proportion of individuals with diverticulosis ≥50 years and male sex were 86.9% (95% CI 80.5-92.1) and 65.2% (95% CI 55.0-74.8), respectively. The left colon had the highest diverticulosis frequency (37% [148/400]). Bleeding/inflammation complications were sparingly detected (OR 0.2 [95% CI 0.03-0.75; p < 0.0001]).

Conclusion: An increasing utilization of colonoscopy revealed approximately a threefold increase in the prevalence rate of colonic diverticulosis in Africa. This pathology was most common in males aged >50. Left colon was predominantly affected. Further studies are needed to demonstrate the effect of westernization of diet.

背景:有必要确定憩室病在传统高纤维饮食消费模式和罕见憩室病发病率的非洲人中的流行病学变化:我们系统地搜索了 PubMed、Scopus、Cochrane Library、African Journal Online (AJOL) 和 Google Scholar。资格标准包括 1985-2022 年间针对无症状和有症状非洲人群的观察性和实验性人类结肠镜检查全文研究。病例报告、会议摘要、学位论文、系统综述以及缺乏结肠镜检查结果的研究均被排除在外。采用 NIH 观察性队列和横断面研究质量评估工具来评估偏倚风险。采用随机效应模型进行 Meta 分析。使用不一致性(I2)统计量评估异质性:结果:共纳入 30 项研究。结肠憩室综合患病率为 9.1%(95%CI 7.1-11.2;I2=96.3%),西非研究的地区患病率最高,为 11.3%(95%CI 7.6-14.9;I2=96.2%)。年龄≥50岁的憩室患者比例和男性比例分别为86.9%(95%CI 80.5-92.1)和65.2%(95%CI 55.0-74.8)。左结肠憩室发生率最高[37%(148/400)]。很少发现出血/炎症并发症[OR 0.2 (95%CI 0.03-0.75;p结论:结肠憩室最常见于 50 岁以上的男性。受影响的主要是左侧结肠。据报道,非洲各地在发现结肠憩室方面存在地区差异。
{"title":"Colonic Diverticulosis at Colonoscopy in Africa: A Systematic Review and Meta-Analysis of Pooled Estimates.","authors":"Emeka Ray-Offor, Stella-Maris Egboh, Rex F O A Ijah, Sameh Hany Emile, Steven D Wexner","doi":"10.1159/000536587","DOIUrl":"10.1159/000536587","url":null,"abstract":"<p><strong>Introduction: </strong>There is need to ascertain any epidemiologic shift of diverticulosis among Africans with traditionally high fiber diet consumption patterns and rare diverticulosis prevalence.</p><p><strong>Methods: </strong>We systematically searched PubMed, Scopus, Cochrane Library, African Journal Online (AJOL), and Google Scholar. Eligibility criteria included full-text observational and experimental human colonoscopy studies on asymptomatic and symptomatic African population from 1985 to 2022. Case reports, conference abstracts, dissertations, systematic reviews, and studies lacking colonoscopy findings were excluded. NIH quality assessment tool for observational cohort and cross-sectional studies was used to assess risk of bias. Meta-analysis was performed using the random-effect model. Heterogeneity was assessed using inconsistency (I2) statistics.</p><p><strong>Results: </strong>Thirty studies were included. Pooled prevalence rate of colonic diverticulosis in the last decade (2012-2022) has increased to 9.7% (95% CI 6.5-13.4; I2 = 97.3%) from 3.5% (95% CI 1.4-6.4; I2 = 62.7%). The highest regional prevalence rate was in West African studies at 11.3% (95% CI 7.6-14.9; I2 = 96.2%). Proportion of individuals with diverticulosis ≥50 years and male sex were 86.9% (95% CI 80.5-92.1) and 65.2% (95% CI 55.0-74.8), respectively. The left colon had the highest diverticulosis frequency (37% [148/400]). Bleeding/inflammation complications were sparingly detected (OR 0.2 [95% CI 0.03-0.75; p &lt; 0.0001]).</p><p><strong>Conclusion: </strong>An increasing utilization of colonoscopy revealed approximately a threefold increase in the prevalence rate of colonic diverticulosis in Africa. This pathology was most common in males aged &gt;50. Left colon was predominantly affected. Further studies are needed to demonstrate the effect of westernization of diet.</p>","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":" ","pages":"63-78"},"PeriodicalIF":1.8,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139912333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contents Vol. 40, 2023 目 录 第 40 卷,2023 年
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-12-01 DOI: 10.1159/000535458
De Pastena, S. Brozzetti, M. Carati, A. V. Sterpetti, Rome, S. R. Henriksen, J. Rosenberg, S. Fonnes, Herlev, G. Mendez-Rico, D. Reyes-Ruiz, P. I. J.M. Moreno-Ley
{"title":"Contents Vol. 40, 2023","authors":"De Pastena, S. Brozzetti, M. Carati, A. V. Sterpetti, Rome, S. R. Henriksen, J. Rosenberg, S. Fonnes, Herlev, G. Mendez-Rico, D. Reyes-Ruiz, P. I. J.M. Moreno-Ley","doi":"10.1159/000535458","DOIUrl":"https://doi.org/10.1159/000535458","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"43 7","pages":"I - VI"},"PeriodicalIF":2.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139018188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contents Vol. 39, 2022 目录2022年第39卷
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-04-27 DOI: 10.1159/000530198

Dig Surg 2022;39:I–VI
中华外科杂志(英文版);2009;31 (1):1 - 6
{"title":"Contents Vol. 39, 2022","authors":"","doi":"10.1159/000530198","DOIUrl":"https://doi.org/10.1159/000530198","url":null,"abstract":"<br />Dig Surg 2022;39:I–VI","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"138 3","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138508430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Front & Back Matter 正面和背面
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-04-01 DOI: 10.1159/000530871
{"title":"Front & Back Matter","authors":"","doi":"10.1159/000530871","DOIUrl":"https://doi.org/10.1159/000530871","url":null,"abstract":"","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"39 1","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43475758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Society News 社会新闻
IF 2.7 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-03-30 DOI: 10.1159/000530303

Dig Surg
{"title":"Society News","authors":"","doi":"10.1159/000530303","DOIUrl":"https://doi.org/10.1159/000530303","url":null,"abstract":"<br />Dig Surg","PeriodicalId":11241,"journal":{"name":"Digestive Surgery","volume":"136 3","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138508431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1